Compare Stocks

2 / 10
Try these comparisons:

Stock Comparison

ATR vs SON

Revenue, margins, valuation, and 5-year total return — side by side.

Live fundamentals10-year financials5-year price chart
ATR
AptarGroup, Inc.

Medical - Instruments & Supplies

HealthcareNYSE • US
Market Cap$8.05B
5Y Perf.+12.3%
SON
Sonoco Products Company

Packaging & Containers

Consumer CyclicalNYSE • US
Market Cap$5.10B
5Y Perf.-0.2%

ATR vs SON — Key Financials

Market cap, revenue, margins, and valuation side-by-side.

Company Snapshot
ATR logoATR
SON logoSON
IndustryMedical - Instruments & SuppliesPackaging & Containers
Market Cap$8.05B$5.10B
Revenue (TTM)$3.87B$7.49B
Net Income (TTM)$387M$1.04B
Gross Margin21.9%20.9%
Operating Margin13.0%8.7%
Forward P/E22.5x8.8x
Total Debt$1.53B$4.85B
Cash & Equiv.$402M$378M

ATR vs SONLong-Term Stock Performance

Price return indexed to 100 at period start. Dividends excluded.

ATR
SON
StockMay 20May 26Return
AptarGroup, Inc. (ATR)100112.3+12.3%
Sonoco Products Com… (SON)10099.8-0.2%

Price return only. Dividends and distributions are not included.

Quick Verdict: ATR vs SON

Each card shows where this stock fits in a portfolio — not just who wins on paper.

Bottom line: SON leads in 6 of 7 categories, making it the strongest pick for growth and revenue expansion and valuation and capital efficiency. AptarGroup, Inc. is the stronger pick specifically for dividend income and shareholder returns. This set spans 2 sectors — these stocks serve different portfolio roles, not just different price points.
ATR
AptarGroup, Inc.
The Long-Run Compounder

ATR is the clearest fit if your priority is long-term compounding and sleep-well-at-night.

  • 83.3% 10Y total return vs SON's 48.6%
  • Lower volatility, beta 0.66, Low D/E 56.4%, current ratio 1.62x
  • 1.4% yield, 33-year raise streak, vs SON's 4.0%
Best for: long-term compounding and sleep-well-at-night
SON
Sonoco Products Company
The Income Pick

SON carries the broadest edge in this set and is the clearest fit for income & stability and growth exposure.

  • Dividend streak 30 yrs, beta 0.53, yield 4.0%
  • Rev growth 41.7%, EPS growth 141.2%, 3Y rev CAGR 8.7%
  • PEG 0.62 vs ATR's 1.75
Best for: income & stability and growth exposure
See the full category breakdown
CategoryWinnerWhy
GrowthSON logoSON41.7% revenue growth vs ATR's 5.4%
ValueSON logoSONLower P/E (8.8x vs 22.5x), PEG 0.62 vs 1.75
Quality / MarginsSON logoSON13.8% margin vs ATR's 10.0%
Stability / SafetySON logoSONBeta 0.53 vs ATR's 0.66
DividendsATR logoATR1.4% yield, 33-year raise streak, vs SON's 4.0%
Momentum (1Y)SON logoSON+21.9% vs ATR's -16.1%
Efficiency (ROA)SON logoSON9.0% ROA vs ATR's 7.6%, ROIC 6.2% vs 10.7%

ATR vs SON — Revenue Breakdown by Segment

How each company's revenue is distributed across its business units

ATRAptarGroup, Inc.
FY 2025
Pharma Segment
57.0%$1.7B
Beauty Segment
43.0%$1.3B
SONSonoco Products Company
FY 2025
Consumer Packaging
66.9%$4.9B
Industrial Paper Packaging Segment
33.1%$2.4B

ATR vs SON — Financial Metrics

Side-by-side numbers across 2 stocks — who leads on profitability, valuation, growth, and risk.

BEST OVERALLATRLAGGINGSON

Income & Cash Flow (Last 12 Months)

ATR leads this category, winning 4 of 6 comparable metrics.

SON is the larger business by revenue, generating $7.5B annually — 1.9x ATR's $3.9B. Profitability is closely matched — net margins range from 13.8% (SON) to 10.0% (ATR). On growth, ATR holds the edge at +10.8% YoY revenue growth, suggesting stronger near-term business momentum.

MetricATR logoATRAptarGroup, Inc.SON logoSONSonoco Products C…
RevenueTrailing 12 months$3.9B$7.5B
EBITDAEarnings before interest/tax$801M$1.2B
Net IncomeAfter-tax profit$387M$1.0B
Free Cash FlowCash after capex$325M$266M
Gross MarginGross profit ÷ Revenue+21.9%+20.9%
Operating MarginEBIT ÷ Revenue+13.0%+8.7%
Net MarginNet income ÷ Revenue+10.0%+13.8%
FCF MarginFCF ÷ Revenue+8.4%+3.6%
Rev. Growth (YoY)Latest quarter vs prior year+10.8%-1.9%
EPS Growth (YoY)Latest quarter vs prior year-4.3%+23.6%
ATR leads this category, winning 4 of 6 comparable metrics.

Valuation Metrics

SON leads this category, winning 7 of 7 comparable metrics.

At 13.0x trailing earnings, SON trades at a 39% valuation discount to ATR's 21.3x P/E. Adjusting for growth (PEG ratio), SON offers better value at 0.92x vs ATR's 1.65x — a lower PEG means you pay less per unit of expected earnings growth.

MetricATR logoATRAptarGroup, Inc.SON logoSONSonoco Products C…
Market CapShares × price$8.1B$5.1B
Enterprise ValueMkt cap + debt − cash$9.2B$9.6B
Trailing P/EPrice ÷ TTM EPS21.28x12.99x
Forward P/EPrice ÷ next-FY EPS est.22.47x8.84x
PEG RatioP/E ÷ EPS growth rate1.65x0.92x
EV / EBITDAEnterprise value multiple11.48x7.77x
Price / SalesMarket cap ÷ Revenue2.13x0.68x
Price / BookPrice ÷ Book value/share3.08x1.42x
Price / FCFMarket cap ÷ FCF26.89x12.99x
SON leads this category, winning 7 of 7 comparable metrics.

Profitability & Efficiency

ATR leads this category, winning 6 of 9 comparable metrics.

SON delivers a 30.0% return on equity — every $100 of shareholder capital generates $30 in annual profit, vs $19 for ATR. ATR carries lower financial leverage with a 0.56x debt-to-equity ratio, signaling a more conservative balance sheet compared to SON's 1.34x. On the Piotroski fundamental quality scale (0–9), SON scores 7/9 vs ATR's 5/9, reflecting strong financial health.

MetricATR logoATRAptarGroup, Inc.SON logoSONSonoco Products C…
ROE (TTM)Return on equity+18.6%+30.0%
ROA (TTM)Return on assets+7.6%+9.0%
ROICReturn on invested capital+10.7%+6.2%
ROCEReturn on capital employed+13.8%+8.3%
Piotroski ScoreFundamental quality 0–957
Debt / EquityFinancial leverage0.56x1.34x
Net DebtTotal debt minus cash$1.1B$4.5B
Cash & Equiv.Liquid assets$402M$378M
Total DebtShort + long-term debt$1.5B$4.9B
Interest CoverageEBIT ÷ Interest expense16.19x4.60x
ATR leads this category, winning 6 of 9 comparable metrics.

Total Returns (Dividends Reinvested)

Evenly matched — ATR and SON each lead in 3 of 6 comparable metrics.

A $10,000 investment in SON five years ago would be worth $9,026 today (with dividends reinvested), compared to $8,472 for ATR. Over the past 12 months, SON leads with a +21.9% total return vs ATR's -16.1%. The 3-year compound annual growth rate (CAGR) favors ATR at 2.4% vs SON's -1.1% — a key indicator of consistent wealth creation.

MetricATR logoATRAptarGroup, Inc.SON logoSONSonoco Products C…
YTD ReturnYear-to-date+2.9%+17.7%
1-Year ReturnPast 12 months-16.1%+21.9%
3-Year ReturnCumulative with dividends+7.4%-3.2%
5-Year ReturnCumulative with dividends-15.3%-9.7%
10-Year ReturnCumulative with dividends+83.3%+48.6%
CAGR (3Y)Annualised 3-year return+2.4%-1.1%
Evenly matched — ATR and SON each lead in 3 of 6 comparable metrics.

Risk & Volatility

SON leads this category, winning 2 of 2 comparable metrics.

SON is the less volatile stock with a 0.53 beta — it tends to amplify market swings less than ATR's 0.66 beta. A beta below 1.0 means the stock typically moves less than the S&P 500. SON currently trades 88.5% from its 52-week high vs ATR's 76.2% drawdown — a narrower gap to the peak suggests stronger recent price momentum.

MetricATR logoATRAptarGroup, Inc.SON logoSONSonoco Products C…
Beta (5Y)Sensitivity to S&P 5000.66x0.53x
52-Week HighHighest price in past year$164.28$58.43
52-Week LowLowest price in past year$103.23$38.65
% of 52W HighCurrent price vs 52-week peak+76.2%+88.5%
RSI (14)Momentum oscillator 0–10042.850.8
Avg Volume (50D)Average daily shares traded473K1.1M
SON leads this category, winning 2 of 2 comparable metrics.

Analyst Outlook

Evenly matched — ATR and SON each lead in 1 of 2 comparable metrics.

Wall Street rates ATR as "Buy" and SON as "Buy". Consensus price targets imply 35.6% upside for ATR (target: $170) vs 14.1% for SON (target: $59). For income investors, SON offers the higher dividend yield at 4.04% vs ATR's 1.45%.

MetricATR logoATRAptarGroup, Inc.SON logoSONSonoco Products C…
Analyst RatingConsensus buy/hold/sellBuyBuy
Price TargetConsensus 12-month target$169.67$59.00
# AnalystsCovering analysts1821
Dividend YieldAnnual dividend ÷ price+1.4%+4.0%
Dividend StreakConsecutive years of raises3330
Dividend / ShareAnnual DPS$1.81$2.09
Buyback YieldShare repurchases ÷ mkt cap+4.5%+0.2%
Evenly matched — ATR and SON each lead in 1 of 2 comparable metrics.
Key Takeaway

ATR leads in 2 of 6 categories (Income & Cash Flow, Profitability & Efficiency). SON leads in 2 (Valuation Metrics, Risk & Volatility). 2 tied.

Best OverallAptarGroup, Inc. (ATR)Leads 2 of 6 categories
Loading custom metrics...

ATR vs SON: Frequently Asked Questions

10 questions · data-driven answers · updated daily

01

Is ATR or SON a better buy right now?

For growth investors, Sonoco Products Company (SON) is the stronger pick with 41.

7% revenue growth year-over-year, versus 5. 4% for AptarGroup, Inc. (ATR). Sonoco Products Company (SON) offers the better valuation at 13. 0x trailing P/E (8. 8x forward), making it the more compelling value choice. Analysts rate AptarGroup, Inc. (ATR) a "Buy" — based on 18 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.

02

Which has the better valuation — ATR or SON?

On trailing P/E, Sonoco Products Company (SON) is the cheapest at 13.

0x versus AptarGroup, Inc. at 21. 3x. On forward P/E, Sonoco Products Company is actually cheaper at 8. 8x. The PEG ratio (P/E divided by earnings growth rate) is the most growth-adjusted single valuation metric: Sonoco Products Company wins at 0. 62x versus AptarGroup, Inc. 's 1. 75x — a PEG below 1. 0 traditionally signals the market is underpricing earnings growth.

03

Which is the better long-term investment — ATR or SON?

Over the past 5 years, Sonoco Products Company (SON) delivered a total return of -9.

7%, compared to -15. 3% for AptarGroup, Inc. (ATR). Over 10 years, the gap is even starker: ATR returned +83. 3% versus SON's +48. 6%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.

04

Which is safer — ATR or SON?

By beta (market sensitivity over 5 years), Sonoco Products Company (SON) is the lower-risk stock at 0.

53β versus AptarGroup, Inc. 's 0. 66β — meaning ATR is approximately 25% more volatile than SON relative to the S&P 500. On balance sheet safety, AptarGroup, Inc. (ATR) carries a lower debt/equity ratio of 56% versus 134% for Sonoco Products Company — giving it more financial flexibility in a downturn.

05

Which is growing faster — ATR or SON?

By revenue growth (latest reported year), Sonoco Products Company (SON) is pulling ahead at 41.

7% versus 5. 4% for AptarGroup, Inc. (ATR). On earnings-per-share growth, the picture is similar: Sonoco Products Company grew EPS 141. 2% year-over-year, compared to 6. 3% for AptarGroup, Inc.. Over a 3-year CAGR, SON leads at 8. 7% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.

06

Which has better profit margins — ATR or SON?

AptarGroup, Inc.

(ATR) is the more profitable company, earning 10. 4% net margin versus 5. 3% for Sonoco Products Company — meaning it keeps 10. 4% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: ATR leads at 13. 6% versus 9. 5% for SON. At the gross margin level — before operating expenses — ATR leads at 29. 6%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.

07

Is ATR or SON more undervalued right now?

The PEG ratio (forward P/E divided by expected earnings growth rate) is the most precise measure of undervaluation relative to growth potential.

By this metric, Sonoco Products Company (SON) is the more undervalued stock at a PEG of 0. 62x versus AptarGroup, Inc. 's 1. 75x. A PEG below 1. 0 is traditionally considered the threshold for growth-adjusted undervaluation. On forward earnings alone, Sonoco Products Company (SON) trades at 8. 8x forward P/E versus 22. 5x for AptarGroup, Inc. — 13. 6x cheaper on a one-year earnings basis. Analyst consensus price targets imply the most upside for ATR: 35. 6% to $169. 67.

08

Which pays a better dividend — ATR or SON?

All stocks in this comparison pay dividends.

Sonoco Products Company (SON) offers the highest yield at 4. 0%, versus 1. 4% for AptarGroup, Inc. (ATR).

09

Is ATR or SON better for a retirement portfolio?

For long-horizon retirement investors, Sonoco Products Company (SON) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β 0.

53), 4. 0% yield). Both have compounded well over 10 years (SON: +48. 6%, ATR: +83. 3%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.

10

What are the main differences between ATR and SON?

These companies operate in different sectors (ATR (Healthcare) and SON (Consumer Cyclical)), which means they face different economic cycles, regulatory environments, and macro sensitivities — making direct comparison nuanced.

In terms of investment character: ATR is a small-cap quality compounder stock; SON is a small-cap high-growth stock. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.

Find Stocks Like These

Explore pre-built screens for each stock's profile, or build a custom screen to find stocks that outperform both.

Stocks Like

ATR

Stable Dividend Mega-Cap

  • Sector: Healthcare
  • Market Cap > $100B
  • Revenue Growth > 5%
  • Net Margin > 5%
Run This Screen
Stocks Like

SON

Income & Dividend Stock

  • Sector: Consumer Cyclical
  • Market Cap > $100B
  • Net Margin > 8%
  • Dividend Yield > 1.6%
Run This Screen
Custom Screen

Beat Both

Find stocks that outperform ATR and SON on the metrics below

Revenue Growth>
%
(ATR: 10.8% · SON: -1.9%)
Net Margin>
%
(ATR: 10.0% · SON: 13.8%)
P/E Ratio<
x
(ATR: 21.3x · SON: 13.0x)

You Might Also Compare

Based on how these companies actually compete and overlap — not just which sector they're filed under.